D.E. Shaw & Co’s Chimerix, Inc. CMRX Stock Holding History

D.E. Shaw & Co’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-278,615	Closed	-$244K	–	4966
2024 Q2	$244K	Sell	278,615 -96,011	-26%	-$91K	﹤0.01%	3997
2024 Q1	$397K	Buy	374,626 +103,057	+38%	+$107K	﹤0.01%	3595
2023 Q4	$261K	Buy	271,569 +21,671	+9%	+$21K	﹤0.01%	3795
2023 Q3	$240K	Sell	249,898 -82,986	-25%	-$90.3K	﹤0.01%	3707
2023 Q2	$403K	Sell	332,884 -149,419	-31%	-$189K	﹤0.01%	3505
2023 Q1	$608K	Sell	482,303 -170,378	-26%	-$278K	﹤0.01%	3456
2022 Q4	$1.21M	Sell	652,681 -115,528	-15%	-$226K	﹤0.01%	3306
2022 Q3	$1.48M	Buy	768,209 +64,182	+9%	+$144K	﹤0.01%	3274
2022 Q2	$1.46M	Buy	704,027 +554,588	+371%	+$1.78M	﹤0.01%	3349
2022 Q1	$684K	Sell	149,439 -539	-0.4%	-$3K	﹤0.01%	4176
2021 Q4	$965K	Buy	149,978 +18,323	+14%	+$110K	﹤0.01%	3957
2021 Q3	$815K	Sell	131,655 -36,286	-22%	-$249K	﹤0.01%	3763
2021 Q2	$1.34M	Sell	167,941 -18,260	-10%	-$152K	﹤0.01%	3303
2021 Q1	$1.79M	Sell	186,201 -311,479	-63%	-$2.86M	﹤0.01%	2675
2020 Q4	$2.4M	Buy	497,680 +9,360	+2%	+$33.9K	﹤0.01%	2442
2020 Q3	$1.22M	Sell	488,320 -50,325	-9%	-$149K	﹤0.01%	2735
2020 Q2	$1.67M	Sell	538,645 -76,484	-12%	-$198K	﹤0.01%	2550
2020 Q1	$886K	Sell	615,129 -297,798	-33%	-$521K	﹤0.01%	2826
2019 Q4	$1.85M	Buy	912,927 +231,934	+34%	+$427K	﹤0.01%	2535
2019 Q3	$1.6M	Buy	680,993 +157,203	+30%	+$454K	﹤0.01%	2524
2019 Q2	$2.26M	Sell	523,790 -298,905	-36%	-$920K	﹤0.01%	2158
2019 Q1	$1.73M	Buy	822,695 +163,401	+25%	+$372K	﹤0.01%	2260
2018 Q4	$1.7M	Buy	659,294 +103,799	+19%	+$348K	﹤0.01%	2288
2018 Q3	$2.16M	Buy	555,495 +47,799	+9%	+$204K	﹤0.01%	2142
2018 Q2	$2.42M	Buy	507,696 +44,453	+10%	+$212K	﹤0.01%	2088
2018 Q1	$2.41M	Buy	463,243 +15,528	+3%	+$78.7K	﹤0.01%	1929
2017 Q4	$2.07M	Sell	447,715 -37,949	-8%	-$181K	﹤0.01%	2116
2017 Q3	$2.55M	Sell	485,664 -21,635	-4%	-$106K	﹤0.01%	1851
2017 Q2	$2.77M	Sell	507,299 -89,303	-15%	-$470K	﹤0.01%	1767
2017 Q1	$3.81M	Buy	596,602 +46,896	+9%	+$266K	0.01%	1456
2016 Q4	$2.53M	Buy	549,706 +90,206	+20%	+$426K	﹤0.01%	1819
2016 Q3	$2.54M	Buy	459,500 +375,821	+449%	+$1.72M	﹤0.01%	1740
2016 Q2	$329K	Buy	83,679 +72,407	+642%	+$358K	﹤0.01%	2996
2016 Q1	$58K	Sell	11,272 -3,228	-22%	-$21.1K	﹤0.01%	3326
2015 Q4	$130K	Buy	+14,500	New	+$522K	﹤0.01%	3644

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co's CMRX Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Chimerix, Inc. (CMRX) in Q3 2024, closing a stake of 278,615 shares — an estimated $244K sold.

D.E. Shaw & Co first reported a position in CMRX in Q4 2015 and held it in 35 quarters. The position peaked at $3.81M in Q1 2017. 65 funds tracked by Wall St. Rank hold CMRX as of Q3 2024.

D.E. Shaw & Co reported no remaining Chimerix, Inc. position as of Q3 2024 after selling out during the quarter.
D.E. Shaw & Co sold 278,615 Chimerix, Inc. shares in Q3 2024, an estimated $244K.
D.E. Shaw & Co first reported a position in Chimerix, Inc. in Q4 2015 and held it in 35 quarters.
D.E. Shaw & Co's Chimerix, Inc. position peaked at $3.81M in Q1 2017.
65 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.